BMY vs ISRG
Based on Invest's signal, Bristol-Myers Squibb Co. (BMY) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus sell for ISRG.
| Metric | BMY | ISRG |
|---|---|---|
| Price | $62.09 | $337.50 |
| Day change | +0.9% | +1.7% |
| Market cap | $126.8B | $120.9B |
| P/E ratio | 18.0 | 41.0 |
| 1-year return | +26.8% | -32.8% |
| Invest signal | Buy | Sell |
Higher market cap, higher 1-year return, lower P/E, and a stronger signal are highlighted. Data is for learning, not financial advice.
Can't decide? Trade both — risk-free.
Start with €1,000,000 in virtual cash and practice buying BMY and ISRG at live prices.
BMY vs ISRG: FAQ
Is BMY or ISRG the better stock to buy?
Based on Invest's signal, Bristol-Myers Squibb Co. (BMY) currently has the stronger Buy/Hold/Sell rating of the two — a buy versus sell for ISRG. Remember that Invest's signal is a data-driven snapshot for learning, not financial advice — the best way to understand the difference is to add both to a watchlist and practice trading them with virtual cash.
Which is bigger, BMY or ISRG?
Bristol-Myers Squibb Co. is the larger company by market capitalisation ($126.8B vs $120.9B).
Can I practice trading BMY and ISRG for free?
Yes. Invest is a free stock market simulator — you start with €1,000,000 in virtual cash and can buy and sell both BMY and ISRG at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.